Journal
FRONTIERS IN PHARMACOLOGY
Volume 13, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2022.1025780
Keywords
hepatocellular carcinoma; MOFs; photothermal therapy; photodynamic therapy; chemodynamic therapy
Categories
Funding
- Beijing Postdoctoral Research Foundation
- [2022-ZZ-056]
Ask authors/readers for more resources
Metal organic frameworks (MOFs) have potential applications in cancer therapy, including enhancing the anticancer effects of photodynamic therapy and photothermal therapy, as well as drug delivery and protection. However, there is a lack of reviews on the application of MOFs in hepatocellular carcinoma.
In recent years, metal organic frameworks (MOFs) have attracted increasing attention in cancer therapy, because they can enhance the anticancer efficacy of photodynamic therapy (PDT), photothermal therapy (PTT), photoacoustic imaging, and drug delivery. Owing to stable chemical adjustability, MOFs can be used as carriers to provide excellent loading sites and protection for small-molecule drugs. In addition, MOFs can be used to combine with a variety of therapeutic drugs, including chemotherapeutics drugs, photosensitizers, and radiosensitizers, to efficiently deliver drugs to tumor tissue and achieve desired treatment. There is hardly any review regarding the application of MOFs in hepatocellular carcinoma. In this review, the design, structure, and potential applications of MOFs as nanoparticulate systems in the treatment of hepatocellular carcinoma are presented.Systematic Review Registration: website, identifier registration number
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available